Kunos G, Ishac E J
J Cardiovasc Pharmacol. 1985;7 Suppl 6:S87-92.
Reciprocal changes in alpha- and beta-receptor responses occur in a number of in vivo as well as in vitro conditions. Incubation of isolated rat liver cells in a serum-free buffer results in the conversion of the adrenergic activation of glycogenolysis from an alpha 1 to a beta-receptor mediated response within 4 h. The decrease in the alpha 1-adrenergic response and the simultaneous emergence of a beta-adrenergic response are selective with regards to the effects of other glycogenolytic hormones and are not accompanied by changes in the density or affinity of alpha 1 or beta-receptor binding sites. Lipomodulin, an endogenous inhibitor of membrane phospholipase A2, reverses the receptor response in 4 h cells from beta to alpha, whereas lipomodulin antibody, or melittin, a phospholipase A2 activator, have opposite effects in freshly isolated cells. The time-dependent conversion of the adrenoceptor response is prevented by the presence of indomethacin or inhibitors of protein or mRNA synthesis, and is accelerated by a serine protease inhibitor. These findings are interpreted to indicate that changes in membrane phospholipase A2 activity are involved in the conversion of the adrenergic receptor response in isolated rat liver cells, by influencing the coupling of alpha 1 and beta-receptors to postreceptor pathways in an inverse, reciprocal manner. The activation of this mechanism requires a protein factor(s), whose cellular levels are controlled by a balance between protein synthetic and proteolytic activities. The possibility that this phospholipase effect is mediated by a cyclooxygenase product is under study.
在许多体内和体外条件下,α受体和β受体反应会发生相互变化。将分离的大鼠肝细胞在无血清缓冲液中孵育4小时后,糖原分解的肾上腺素能激活从α1受体介导的反应转变为β受体介导的反应。α1肾上腺素能反应的降低以及β肾上腺素能反应的同时出现,对于其他糖原分解激素的作用具有选择性,并且不伴随着α1或β受体结合位点的密度或亲和力的变化。脂调素是膜磷脂酶A2的内源性抑制剂,它能使4小时细胞中的受体反应从β型转变为α型,而脂调素抗体或磷脂酶A2激活剂蜂毒素在新鲜分离的细胞中具有相反的作用。消炎痛或蛋白质或mRNA合成抑制剂的存在可阻止肾上腺素能受体反应的时间依赖性转变,而丝氨酸蛋白酶抑制剂可加速这种转变。这些发现被解释为表明膜磷脂酶A2活性的变化通过以相反、相互的方式影响α1和β受体与受体后途径的偶联,参与了分离的大鼠肝细胞中肾上腺素能受体反应的转变。这种机制的激活需要一种蛋白质因子,其细胞水平由蛋白质合成和蛋白水解活性之间的平衡控制。这种磷脂酶效应是否由环氧化酶产物介导正在研究中。